Mathers C.,Mascarenhas M. .2009 .Global health risks: mortality and burden of disease attributable to selected major risks. , : .
Kovesdy C.P. .2022 .. Epidemiology of chronic kidney disease: an update 2022, Kid. Int. Suppl., 12 : 7-11.
Liu F.X.,Gao X.,Chuengsaman P.,Pecoits-Filho R.,Yu A. .2015 .A global overview of the impact of peritoneal dialysis first or favored policies: an opinion, Perit. , 35 : 406-420.
M.C.C. Andreoli C.,Totoli C. .2020 .. Rev. Assoc. Med, 66 : s37-s44.
Saran R.,Robinson B.,Abbott K.C.,Agodoa L.Y.,Albertus P.,Ayanian J.,Balkrishnan R.,Bragg-Gresham J.,Cao J.,Chen J.L.,Cope E.,Dharmarajan S.,Dietrich X.,Eckard A.,Eggers P.W.,Gaber C.,Gillen D.,Gipson D.,Gu H.,Hailpern S.M.,Hall Y.N.,He K.,Hebert H.,Helmuth M.,Herman W.,Heung M.,Hutton D.,Jacobsen S.J.,Ji N.,Jin Y.,KalantarZadeh K.,Katz R.,Kovesdy C.P.,Kurtz V.,Lavalee D.,Li Y.,Lu Y.,McCullough K.,Molnar M.Z.,Montez-Rath M.,Morgenstern H.,Mu Q.,Mukhopadhyay P.,Nallamothu B.,Nguyen D.V.,Norris K.C.,A.M. O'Hare Y.,Obi J.,Pearson R.,Pisoni B.,Plattner F.K.,Port P.,Potukuchi P.,Rao K.,Ratkowiak V.,Ravel D.,Ray C.M.,Rhee D.E.,Schaubel D.T.,Selewski S.,Shaw J.,Shi M.,Shieu J.J.,Sim P.,Song M.,Soohoo D.,Steffick M.K.,Tamura F.,Tentori A.,Tilea L.,Tong M.,Turf D.,Wang M.,Wang K.,Woodside A.,Wyncott X.,Xin W.,Zang L.,Zepel S.,Zhang R.A.,Hirth V.,Shahinian V. .2017 .. US Renal Data System 2016 Annual Data Report: Epidemiology of Kidney Disease in the United States, Am. J. Kidney Dis, 69 : A7.
Cullis B.,Abdelraheem M.,Abrahams G.,Balbi A.,Cruz D.N.,Frishberg Y.,Koch V.,McCulloch M.,Numanoglu A.,Nourse P. .2014 .Peritoneal dialysis for acute kidney injury. Perit. Dial. Int., 34 : 494-517.
P.K.T. Li W.,Lu S.K.,Mak N.,Boudville X.,Yu X.,M.J. Wu X.,Chan B.L.,Goh N.,Tian N. .2022 .Peritoneal dialysis first policy in Hong Kong for 35 years: Global impact. Nephrology, 27 : 787-794.
K.T. Mills Y.,Xu W.,Zhang J.D.,Bundy T.N.,Kelly J.,Chen J.,He J. .2015 .A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010, Kidney Int. , 88 : 950-957.
Qayyum A.,Kid Pak. J. .2020 .Opinion: Peritoneal Dialysis In Pakistan: An Insider's View. State of Affairs and Planning?,. , 4 : .
C. Voinescu R.,Khanna R. .2002 .. Int. J. Artif. Organs., 25 : 249-260.
Tolonen M.,Ball C.,Kirkpatrick A. .2021 .Secondary peritonitis and intra-abdominal sepsis: an increasingly global disease in search of better systemic therapies. Scand. J. Surg., 110 : 139-149.
.2018 .Peritoneal dialysis-related peritonitis: challenges and solutions. Int. J. Nephrol. Renovasc. Dis., 11 : 173-186.
P.K.-T. Li C.C.,Szeto B.,Piraino S.,Fan A.E.,Figueiredo D.N.,Fish Y.- L.,Kim Y.- L. .2016 .ISPD peritonitis recommendations: 2016 update on prevention and treatment, Perit. , 36 : 481-508.
J.R. Ghali ,K.M. Bannister F.G.,Brown F.G.,Rosman K.J.,Wiggins D.W.,Johnson S.P.,McDonald S.P. .2011 .Microbiology and outcomes of peritonitis in Australian peritoneal dialysis patients. Perit. Dial. Int., 31 : 651-662.
Dahbour J.,Gibbs C.,Coletta J.,Hummell M.,Al-Sarie N.P.,Kahlon B.,Akpunonu B. .2020 .Peritoneal dialysis zoonotic bacterial peritonitis with Staphylococcus pseudintermedius. Case Rep. Nephrol. Dial., 10 : 65-70.
Mehrotra R.,Devuyst O.,Davies S.J.,Johnson D.W. .2016 .The current state of peritoneal dialysis. J. Am. Soc. Nephrol., 27 : 3238-3252.
Briggs V.,Davies S. .2019 .International variations in peritoneal dialysis utilization and implications for practice. Am. J. Kidney Dis, 74 : 101-110.
Brown E.A. .2020 .Increasing peritoneal dialysis use in response to the COVID-19 pandemic: will it go viral?. J. Am. Soc. Nephrol., 31, : 1928-1930.
Piraino B.,Bailie G.R.,Bernardini J.,Boeschoten E.,Gupta A.,Holmes C.,Kuijper E.J.,P.K.-T. Li W.-C.,Lye S.,Mujais S. .2005 .Peritoneal dialysis-related infections recommendations: 2005 update. Perit. Dial. Int., 25 : 107-131.
Tartaglione R.E.,Polk R.E. .1985 .Review of the new second-generation cephalosporins: cefonicid, ceforanide, and cefuroxime. Drug Intell. Clin. Pharm, 19 : 188-198.
Grotelueschen R.,Luetgehetmann M.,Erbes J.,Heidelmann L.M.,Grupp K.,Karstens K.,Ghadban T.,Reeh M.,Izbicki J.R.,Bachmann K. .2019 .Microbial findings, sensitivity and outcome in patients with postoperative peritonitis a retrospective cohort study. Int. Surg. J., 70 : 63-69.
Hui-Min Q.,Leung L. S.,Cheung S. W. .2001 .Is a first-or second-generation cephalosporin-based regime a suitable first-line antibiotic treatment for continuous ambulatory peritoneal dialysis peritonitis?. Hong Kong J. Nephrol., 3 : 15-20.
Corradini D.,Eksteen R.,Schoenmakers P.,Miller N. .1998 .. , : .
Hemström P.,Irgum K. .2006 .. J. Sep. Sci., 29 : 1784-1821.
Ranganathan D.,Naicker S.,Wallis S.C.,Lipman J.,Ratanjee S.K.,Roberts J.A. .2016 .Stability of antibiotics for intraperitoneal administration in extraneal 7.5% icodextrin peritoneal dialysis bags (STAB Study). Perit. Dial. Int., 36 : 421-426.
Mendes K.,Harmanjeet H.,Sedeeq M.,Modi A.,Wanandy T.,Zaidi S.T.R.,Ming L.C.,Castelino R.L.,Sud K.,Peterson G.M. .2018 .Stability of meropenem and piperacillin/tazobactam with heparin in various peritoneal dialysis solutions. Perit. Dial. Int., 38 : 430-440.
Lian-Jie F.,Jia.Hui M.,Kai-Lli Z. .2012 .Content determination of cefuroxime in peritoneal dialysis solution by HPLC and compatible stability of the mixture. , 25 : 2378-2379.
C. Vercheval S.,Streel A.-C.,Servais M.,Fillet T. Van Hees .2018 .Stability of 90 mg/mL cefuroxime sodium solution for administration by continuous infusion. , 30 : 371-374.
Helin-Tanninen J.,Mustonen M.,Lehtonen O.,Korhonen O. .2018 .-012 Stability of cefuroxime 80 mg/ml solution in ready-to-administer polypropylene syringes. Eur. J. Hosp. Pharm., 25 : .
Ye Q.,Zhou L.,Fan Q.,Guo H.,Mao F.,Huang X.,Yu X.,Yang X. .2017 .The impact of peritoneal dialysis-related peritonitis on mortality in peritoneal dialysis patients, BMC Nephrol. , 18 : 1-9.
So S.W.Y.,Chen L.,Woo A.Y.H.,Ng D.M.H.,Wong J.K.W.,K.M. Chow N.,Runnegar D.W.,Johnson D.W.,P.K.-T. Li D.W. .2022 .Stability and compatibility of antibiotics in peritoneal dialysis solutions, Clin. , 15 : 1071-1078.